Owner Novartis AG

Inventors Matharu, Amol Singh; Bock, Michaela Anna Maria; Wolf, Marie-Christine; Wen, Hong; Loggia, Nicoletta; Babiole Saunier, Maggy; Bargenda, Nicole; Hirsch, Stefan; Vippagunta, Sudha; Buss, Bruno; Kowalski, James; Tong, Wei-Qin; Adler, Sabine; Altenburger, Ralf; Keller, Patrice Francois; Kochhar, Charu; Lakshman, Jay Parthiban; Taillemite, Julien; Curdy, Catherine; Li, Shoufeng; Ghosh, Indrajit

Agent Davies Collison Cave

Pub. Number AU-B-2008309058

PCT Pub. Number WO2009/045795

Priority 60/975,919 28.09.07 US; 60/975,925 28.09.07 US; 60/975,909 28.09.07 US; 60/975,901 28.09.07 US

Filing date 24 September 2008

Wipo publication date 9 April 2009

Acceptance publication date 9 August 2012

A61K 9/22 Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/24 Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 9/48 Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 9/50 Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/165 - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 45/06 Medicinal preparations containing active ingredients not provided for in groups